Effects of Clinical Pilates and Whole Body Vibration Exercises in Postmenopausal Osteoporotic Women

February 5, 2020 updated by: Burcu Ece KORKMAZ, Dokuz Eylul University

Comparison of the Effects of Clinical Pilates and Whole Body Vibration Exercises on Strength, Flexibility, Balance, Bone Turnover Markers and Quality of Life in Postmenopausal Osteoporotic Women

The aim is to compare the effects of clinical pilates and whole body vibration exercises in postmenopausal osteoporotic women on strength, flexibility, balance, bone turnover markers and quality of life.

Study Overview

Status

Unknown

Conditions

Detailed Description

The aim of this study is to compare the effects of clinical pilates and whole body vibration exercises in postmenopausal osteoporotic women in terms of strength, flexibility, balance, bone turnover markers and quality of life. Thirty-four women who are diagnosed with postmenopausal osteoporosis will be recruited into the study. Participants will be divided into two groups: (1) clinical pilates group, (2) vibration exercises group. Exercise programs will be performed two times per week for twelve weeks. The strength of the extensor muscles of the hip, knee, back, elbow will be measured with a hand-held dynamometer. Flexibility will be assessed measuring the fingertip-to-floor distance in flexion and lateral bending. The balance performance will be assessed using the timed up and go test, Tetrax fall index and the maximum hold time on unipedal stance and on tandem stance. The short form-12 questionnaire will be used to assess the quality of life. Also, bone turnover markers will be measured. All assessments will be performed before and after exercise programs.

Study Type

Interventional

Enrollment (Anticipated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Izmir, Turkey, 340
        • Dokuz Eylul University, School of Physical Therapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Being in the postmenopausal period
  • Having body mass index equal to or greater than 18,5 kg/m²
  • A lack of regular exercise
  • Having been diagnosed with osteoporosis
  • Having the ability to walk independently

Exclusion Criteria:

  • Having a cardiopulmonary problem that may prevent participating in exercise programs
  • Having kidney stones
  • Being diagnosed with diabetes
  • Presence of epilepsy
  • Having cardiological problems such as arrhythmia, using a pacemaker, hypertension
  • Having neurological disorders such as Parkinson, stroke, multiple sclerosis, neuropathy
  • Having surgery in the last 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Clinical pilates
Exercises will be performed two times per week for twelve weeks.
Clinical pilates exercises will be performed progressively. The duration of each exercise session will be an average of 40 minutes initially and then will be increased to 60 minutes as the program progress.
EXPERIMENTAL: Whole body vibration
Exercises will be performed two times per week for twelve weeks.
Whole body vibration exercises will be performed using the Power Plate pro5 AIRdaptive machine.The duration of each exercise session will be an average of 20 minutes initially and then will be increased to 30 minutes as the program progress.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength
Time Frame: Change in strength measures from baseline to twelve weeks
The strength of the extensor muscles of the hip, knee, back, elbow will be assessed with a hand-held dynamometer.
Change in strength measures from baseline to twelve weeks
Flexibility
Time Frame: Change in flexibility measures from baseline to twelve weeks
Flexibility wil be assessed measuring the fingertip-to-floor distance in flexion and lateral bending.
Change in flexibility measures from baseline to twelve weeks
Timed up and go test
Time Frame: Change in Timed up and go test from baseline to twelve weeks
Timed up and go test will be used to assess dynamic balance.
Change in Timed up and go test from baseline to twelve weeks
The maximum hold time on unipedal stance and on tandem stance.
Time Frame: Change in the maximum hold time from baseline to twelve weeks
The maximum hold time will be calculated to assess static balance.
Change in the maximum hold time from baseline to twelve weeks
Tetrax fall index
Time Frame: Change in Tetrax fall index from baseline to twelve weeks
Tetrax fall index will be calculated to determine fall risk.
Change in Tetrax fall index from baseline to twelve weeks
The short form-12 questionnaire
Time Frame: Change in quality of life measure from baseline to twelve weeks
The short form-12 questionnaire will be used to assess quality of life. The total score can range from 0 to 100. Lower SF-12 score indicated poorer physical and mental health.
Change in quality of life measure from baseline to twelve weeks
Dual-energy X-ray absorptiometry of hip and lumbar spine
Time Frame: Change in the Dual-energy X-ray absorptiometry of hip and lumbar spine from baseline to twelve weeks
Dual-energy X-ray absorptiometry of hip and lumbar spine will be measured to assess bone density.
Change in the Dual-energy X-ray absorptiometry of hip and lumbar spine from baseline to twelve weeks
Plasma sclerostin concentration
Time Frame: Change in plasma sclerostin concentration from baseline to twelve weeks
Plasma sclerostin concentration will be measured to assess the process of bone resorption and formation.
Change in plasma sclerostin concentration from baseline to twelve weeks
Urinary deoxypyridinoline
Time Frame: Change in urinary deoxypyridinoline level from baseline to twelve weeks
Urinary deoxypyridinoline level will be measured to assess bone resorption.
Change in urinary deoxypyridinoline level from baseline to twelve weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 15, 2018

Primary Completion (ANTICIPATED)

April 15, 2020

Study Completion (ANTICIPATED)

May 15, 2020

Study Registration Dates

First Submitted

February 2, 2020

First Submitted That Met QC Criteria

February 5, 2020

First Posted (ACTUAL)

February 6, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 6, 2020

Last Update Submitted That Met QC Criteria

February 5, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoporosis

Clinical Trials on Clinical pilates

Subscribe